38 documents found, page 1 of 4

Sort by Issue Date

Correction to: Endothelial dysfunction in cardiovascular diseases: mechanisms a...

Grego, Ana; Fernandes, Cristiana; Fonseca, Ivo; Dias-Neto, Marina; Costa, Raquel; Leite-Moreira, Adelino; Oliveira, Sandra Marisa; Trindade, Fabio


Endothelial dysfunction in cardiovascular diseases: mechanisms and in vitro models

Grego, Ana; Fernandes, Cristiana; Fonseca, Ivo; Dias-Neto, Marina; Costa, Raquel; Leite-Moreira, Adelino; Oliveira, Sandra Marisa; Trindade, Fábio

Endothelial cells (ECs) are arranged side-by-side to create a semi-permeable monolayer, forming the inner lining of every blood vessel (micro and macrocirculation). Serving as the first barrier for circulating molecules and cells, ECs represent the main regulators of vascular homeostasis being able to respond to environmental changes, either physical or chemical signals, by producing several factors that regula...


A Portuguese expert panel position paper on the management of heart failure wit...

Silva-Cardoso, José; Moreira, Emília; Melo, Rachel Tavares de; Moraes-Sarmento, Pedro; Cardim, Nuno; Oliveira, Mário; Gavina, Cristina; Moura, Brenda

In Portugal, a 15.2% prevalence of heart failure with preserved ejection fraction (HFpEF) was recently identified among those aged ≥50 years. HFpEF represents 90% of Portuguese heart failure patients. HFpEF management in Portugal is challenging due to patient heterogeneity, diagnostic and therapeutic complexity, and organizational constraints on the healthcare system. Considering the above, a panel of Portugues...


A Portuguese expert panel position paper on the management of heart failure wit...

Silva-Cardoso, José; Moreira, Emília; Melo, Rachel Tavares de; Moraes-Sarmento, Pedro; Cardim, Nuno; Oliveira, Mário; Gavina, Cristina; Moura, Brenda

Heart failure (HF) with preserved ejection fraction (HFpEF) affects more than 50% of HF patients worldwide, and more than 70% of HF patients aged over 65. This is a complex syndrome with a clinically heterogeneous presentation and a multifactorial pathophysiology, both of which make its diagnosis and treatment challenging. A Portuguese HF expert panel convened to address HFpEF pathophysiology and therapy, as we...


A Portuguese Expert Panel Position Paper on the Management of Heart Failure wit...

Silva-Cardoso, José; Moreira, Emília; Tavares de Melo, Rachel; Moraes-Sarmento, Pedro; Cardim, Nuno; Oliveira, Mário; Gavina, Cristina; Moura, Brenda

In Portugal, a 15.2% prevalence of heart failure with preserved ejection fraction (HFpEF) was recently identified among those aged ≥50 years. HFpEF represents 90% of Portuguese heart failure patients. HFpEF management in Portugal is challenging due to patient heterogeneity, diagnostic and therapeutic complexity, and organizational constraints on the healthcare system. Considering the above, a panel of Portugues...


A Portuguese expert panel position paper on the management of heart failure wit...

Silva-Cardoso, José; Moreira, Emília; Tavares de Melo, Rachel; Moraes-Sarmento, Pedro; Cardim, Nuno; Oliveira, Mario; Gavina, Cristina; Moura, Brenda

Heart failure (HF) with preserved ejection fraction (HFpEF) affects more than 50% of HF patients worldwide, and more than 70% of HF patients aged over 65. This is a complex syndrome with a clinically heterogeneous presentation and a multifactorial pathophysiology, both of which make its diagnosis and treatment challenging. A Portuguese HF expert panel convened to address HFpEF pathophysiology and therapy, as we...


Investigator-Led Clinical Research in Portugal: Problem Identification and Prop...

Ferreira, João Pedro; Leite-Moreira, Adelino; da Costa-Pereira, Altamiro; Soares, António José; Robalo-Cordeiro, Carlos; Jerónimo, Cármen

N/a.; N/a.

Date: 2023   |   Origin: Acta Médica Portuguesa

Investigação clínica da iniciativa do investigador em Portugal: identificação d...

Ferreira, João Pedro; Leite-Moreira, Adelino; Da Costa-Pereira, Altamiro; Soares, António José; Robalo-Cordeiro, Carlos; Jerónimo, Cármen

Portugal tem um problema cronico de subfinanciamento da investigacao cientifica. Apesar do investimento nacional ter vindo a aumentar nos ultimos anos, este ainda e manifestamente insuficiente.1 A Fundacao para a Ciencia e Tecnologia (FCT) financia anualmente projetos de investigacao em todas as areas cientificas, limitando o valor maximo a euro250 000 por projeto. Todavia, a area cientifica na qual a investiga...


Galectin-3 in prostate cancer and heart diseases: a biomarker for these two fri...

Lima, Tânia; Perpétuo, Luís; Henrique, Rui; Fardilha, Margarida; Leite-Moreira, Adelino; Bastos, Jose; Vitorino, Rui

Galectin-3 (Gal-3) belongs to galectin protein family, a type of β-galactose-binding lectin having more than one evolutionarily conserved domain of carbohydrate recognition. Gal-3 is mainly located in the cytoplasm, but it also enters the nucleus and is secreted into the extracellular environment and biological fluids such as urine, saliva, and serum. It plays an important role in many biological functions, suc...


Exercise training impacts skeletal muscle remodelling induced by metabolic synd...

Nogueira-Ferreira, Rita; Santos, Inês; Ferreira, Rita; Fontoura, Dulce; Sousa-Mendes, Cláudia; Falcão-Pires, Inês; Lourenço, André P.

Metabolic syndrome (MetS), characterized by a set of conditions that include obesity, hypertension, and dyslipidemia, is associated with increased cardiovascular risk. Exercise training (EX) has been reported to improve MetS management, although the underlying metabolic adaptations that drive its benefits remain poorly understood. This work aims to characterize the molecular changes induced by EX in skeletal mu...


38 Results

Queried text

Refine Results

Author





















Date










Document Type








Funding



Access rights



Resource















Subject